Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
TSE:4528
Price:
2 452
JPY
-0.99%
Market Cap:
¥1.2T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ono Pharmaceutical Co Ltd
TSE:4528
|
JP |
|
Renaissance United Ltd
SGX:I11
|
SG |
|
L
|
Linkers Industries Ltd
NASDAQ:LNKS
|
MY |
|
Beijing Kingee Culture Development Co Ltd
SZSE:002721
|
CN |
|
Shalimar Paints Ltd
NSE:SHALPAINTS
|
IN |
|
M
|
Magna Polonia SA
WSE:06N
|
PL |
|
A
|
Amyris Inc
F:3A01
|
US |
|
H
|
Hanil Cement Co Ltd
KRX:300720
|
KR |
|
A
|
Al-Saif Stores for Development & Investment Company SJSC
SAU:4192
|
SA |
|
S
|
Shanghai Electric Group Co Ltd
XBER:USR
|
CN |
|
F
|
F-Code Inc
TSE:9211
|
JP |
|
A
|
Advanced Optoelectronic Technology Inc
TWSE:3437
|
TW |
|
Voya Financial Inc
NYSE:VOYA
|
US |
|
Nihon Parkerizing Co Ltd
TSE:4095
|
JP |
|
S
|
Shanghai Tianchen Co Ltd
SSE:600620
|
CN |
|
KEPCO Plant Service & Engineering Co Ltd
KRX:051600
|
KR |
|
Scala Inc
TSE:4845
|
JP |
|
S
|
Samyang Holdings Corp
KRX:000075
|
KR |
|
H
|
Hubei Mailyard Share Co Ltd
SSE:600107
|
CN |
|
Toho Gas Co Ltd
TSE:9533
|
JP |
|
Golden Eagle Retail Group Ltd
HKEX:3308
|
CN |
|
N
|
NTN Corp
TSE:6472
|
JP |
|
Gold Standard Ventures Corp
TSX:GSV
|
CA |
|
C
|
Carlyle Group Inc
F:3VU
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Ono Pharmaceutical Co Ltd (4528)
under the Base Case is
hidden
JPY.
Compared with the current market price of 2 452 JPY, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Ono Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Ono Pharmaceutical Co Ltd Competitors
Ono Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Ono Pharmaceutical Co Ltd
TSE:4528
|
1.2T JPY | 2.2 | 18.3 | 9.2 | 13.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13.4 | 42.3 | 28.6 | 30.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.6 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP | 2.7 | 15.4 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
